Skip to main content
Medical information Clinical review pending

Infection Testing

Metapneumonia Virus A Viral Load Quantitative Test

The Metapneumonia Virus A Viral Load Quantitative Test measures the amount of metapneumonia virus in respiratory samples. This test helps assess infection severity and guide treatment, particularly for those with respiratory symptoms or weakened immune systems.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Bronchial Swab, Bronchial Lavage, Sputum, Nasopharyngeal (NP) aspirates and swabs in viral transport medium, Lung tissues.
Results
Confirm with the laboratory before booking.
Preparation
Patients are required to sign a consent document. Please provide relevant clinical history related to your condition to the laboratory or your healthcare provider.
Test priceKSh 17,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Metapneumonia Virus A Viral Load Quantitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Patients with respiratory symptoms (cough, wheezing, difficulty breathing)
  • ✓Individuals with suspected metapneumonia virus infection
  • ✓Patients with compromised immune systems
  • ✓Monitoring response to antiviral treatment
  • ✓Assessing infection severity
02

In plain language

What this test helps you understand

This test helps determine the severity of a metapneumonia virus infection by measuring the viral load in respiratory samples. It aids clinicians in making treatment decisions and monitoring the response to therapy.
The Metapneumonia Virus A Viral Load Quantitative Test is a diagnostic tool used to measure the concentration of metapneumonia virus in respiratory samples. This test is important for understanding the severity of the infection and helping healthcare providers make informed treatment decisions.

This test quantitatively detects the presence of the metapneumonia virus in samples like bronchial swabs, bronchial lavage, sputum, nasopharyngeal aspirates, and lung tissues. Measuring the viral load helps determine the extent of the infection and guides treatment strategies.

Individuals experiencing respiratory symptoms such as persistent cough, wheezing, or difficulty breathing may benefit from this test. People with underlying health conditions or compromised immune systems are also encouraged to consider testing for early diagnosis and management.

Benefits of this test include early detection of the virus, informing treatment decisions based on viral load, monitoring the effectiveness of antiviral therapies, and providing valuable information for patient care.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationPatients are required to sign a consent document. Please provide relevant clinical history related to your condition to the laboratory or your healthcare provider.
SampleBronchial Swab, Bronchial Lavage, Sputum, Nasopharyngeal (NP) aspirates and swabs in viral transport medium, Lung tissues.
MethodologyQuantitative molecular testing (e.g., PCR) to measure viral load.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
The test detects Metapneumonia Virus A. Results should be interpreted alongside clinical findings and other diagnostic tests. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Metapneumonia virus is a common respiratory virus that can cause illness ranging from mild cold-like symptoms to severe respiratory infections, particularly in young children, older adults, and those with weakened immune systems.
Measuring the viral load helps determine the amount of virus present in the body. A higher viral load may indicate a more severe infection and can guide treatment decisions and monitoring.
Samples typically include respiratory specimens such as bronchial swabs, bronchial lavage fluid, sputum, nasopharyngeal aspirates or swabs, and lung tissue.
Confirm with the laboratory before booking.
Individuals with respiratory symptoms, those suspected of having a metapneumonia virus infection, and people with weakened immune systems may benefit from this test.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp